For decades, the standard treatment for these potentially ... benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years.

For decades, the standard treatment for these potentially ... benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years.

The scan method has enabled the team, led by researchers at Newcastle University, UK, to see how air moves in and out of the ...

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

For the first time in 50 years, a new treatment has been found to improve care for people experiencing asthma or COPD (chronic obstructive pulmonary disease) attacks. A drug called benralizumab ...

The first new treatment for asthma attacks in 50 years ... said their study shows “massive promise” for asthma and COPD treatment. “COPD is the third leading cause of death worldwide ...

New imaging techniques reveal real-time lung function improvements, offering a breakthrough in diagnosing and treating ...

A new method of scanning lungs is able to show the effects of treatment on lung function in real time and enable experts to ...

A new injection using benralizumab is more effective than steroid tablets in treating asthma and COPD exacerbations, reducing the need for further treatment by 30%. This breakthrough could ...

Scientists at Newcastle University have developed a new lung scanning method that reveals the real-time effects on lung ...

Lung Cancer Foundation head Philip Hope said the announcement met the greatest treatment need right ... inhaler is expected to help 5000 New Zealanders with COPD in the first year of funding ...